Solution: Federal And State Policy

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Policy, Research, and Analysis

ADVI Instant: CMS Issues MFPs for the First 10 Drugs Selected for Government Negotiation
In The News Lindsay Bealor Greenleaf Interviewed by Pharmacy Times on IRA Drug Pricing Announcement
In The News Lindsay Bealor Greenleaf Discusses IRA Negotiated Drug Prices with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf Shares IRA Insights In Axios

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Policy, Research, and Analysis

ADVI Instant: CMS Releases Final Part Two Guidance for the MPPP Program

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Policy, Research, and Analysis

ADVI Instant: CMS Releases the FY 2025 IPPS Final Rule

Case Study: Strengthening Positioning for IRA Drug Price Negotiation
In The News Lindsay Bealor Greenleaf Speaks with Politico on Possible Vice President Harris Nomination in the 2024 Presidential Election
In The News Lindsay Bealor Greenleaf Speaks with Politico on Shifts in the 2024 Presidential Election